We are thrilled to partner with Multiply Labs, which allows us to contribute to innovative solutions in the pharmaceutical and biotech sectors. 🎯 Thanks to our expertise in sterilization for the automated production of cell therapies, Fedegari Group is continuously developing. We look forward to sharing our upcoming developments and innovative solutions with you. 👉 Stay tuned for more updates!
2024 has been one of the best years yet for us…and we're only halfway through! We started the year off by releasing exciting performance results for our proof-of-concept robotic system. This couldn't have happened without the help of our incredible collaborators at University of California, San Francisco, Cytiva, Thermo Fisher Scientific and Charles River Laboratories. Publishing this peer reviewed research on Cytotherapy was a big milestone, because it let the world know that a cell therapy expansion process automated with our technology is statistically equivalent to the corresponding manual process. We also continued building out our industry-leading partner ecosystem to offer automation for more GMP-instruments than ever before. In just the first half of this year we: 🧬Collaborated with Fedegari Group to add sterilization to automated cell therapy manufacturing 🧬 Initiated a groundbreaking collaboration with Stanford GMP Facility: Laboratory for Cell and Gene Medicine for Cell and Gene medicine to demonstrate the potential of automation technology for cell therapy manufacturing 🧬 Expanded our partnership with Thermo Fisher Scientific to automate closed-system centrifugation in cell therapy manufacturing 🧬 Partnered with GenScript to collaborate on the automation of the cell isolation and enrichment phase of cell therapy manufacturing 🧬 Teamed up with Wilson Wolf Manufacturing, LLC to automate their industry-leading G-Rex® bioreactors 🧬 Started automating Portal’s nonviral cell engineering platform 🎉 AND we signed a major commercial partnership with Retro Biosciences to advance automated cell therapy manufacturing for age-related diseases With another 6 months to go, we can’t wait to see what the rest of 2024 has in store! #Celltherapy #pharma #biotech #manufacturing